Barostim in HFrEF Patients: International Strategies for Patient Selection and Management HFA 2024 Discussion

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Barostim in HFrEF Patients: International Strategies for Patient Selection and Management HFA 2024 Discussion

By CVRx | Barostim FEATURING Johann Bauersachs, Philip Wenzel, Stefan Anker, William Abraham, Patrick Mccann

0 views

July 31, 2024

Hear discussion and insights from Prof. Dr. med. Stefan Anker, Dr. William Abraham, Dr. Patrick McCann, Prof. Dr. med. Philip Wenzel, and Prof. Dr. med. Johann Bauersachs following the HFA 2024 symposium.

Comments 0

Challenges and Opportunities with Contemporary GDMT in NYHA Class II…

Feat. W. Abraham